Journal of Vascular Surgery
Volume 50, Issue 4 , Pages 806-812 , October 2009

The consequences of an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for critical leg ischemia

  • Maria Söderström, MD

      Affiliations

    • Department of Vascular Surgery, Helsinki University Central Hospital, Helsinki, Finland
    • Corresponding Author InformationCorrespondence: Maria Söderström, MD, Department of Vascular Surgery, Helsinki University Central Hospital, Finland
    • ,
  • Pirkka Vikatmaa, MD

      Affiliations

    • Department of Vascular Surgery, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Mauri Lepäntalo, MD, PhD

      Affiliations

    • Department of Vascular Surgery, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Pekka-Sakari Aho, MD, PhD

      Affiliations

    • Department of Vascular Surgery, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Elina Kolho, MD, PhD

      Affiliations

    • Department of Internal Medicine, Division of Infectious Diseases, Helsinki University Central Hospital, Helsinki, Finland
    • ,
  • Tuija Ikonen, MD, PhD

      Affiliations

    • Department of Vascular Surgery, Helsinki University Central Hospital, Helsinki, Finland
    • Department of Surgery, Turku University Central Hospital, Helsinki, Finland

Received 29 March 2009 ,Accepted 29 May 2009.

References 

  1. Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multi-drug resistant Pseudomonas aeruginosa; risk factors and clinical impact. Antimicrob Agents Chemother. 2006;50:43–48
  2. Agodi A, Barchitta M, Cipreso R, Giaquinta L, Romeo M, Denaro C. Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients. Intensive Care Med. 2007;33:1155–1161
  3. Hocquet D, Berthelot P, Roussel-Delvallez M, Favre R, Jeannot K, Bajolet O, et al. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob Agents Chemother. 2007;10:3531–3536
  4. Hancock R. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis. 1998;27(suppl 1):S93–S99
  5. Lyytikäinen O, Golovanova V, Kolho E, Ruutu P, Sivonen A, Tiittanen L, et al. Outbreak caused by Tobramycin-resistant Pseudomonas auruginosa in a Bone Marrow Transplantation Unit. Scand J Infect Dis. 2001;33:445–449
  6. Cao B, Wang H, Sun H, Zhu Y, Chen M. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections. J Hosp Infect. 2004;57:112–118
  7. Zavascki A, Barth A, Gonçalves A, Moro A, Fernandes J, Martins A, et al. The influence of metallo-ß-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother. 2006;58:387–392
  8. Gasink L, Fishman N, Weiner M, Nachamkin I, Bilker W, Lautenbach E. Fluoroquinolone-resistant Pseudomonas aeruginosa assessment of risk factors and clinical impact. Am J Med. 2006;119:526e19-25
  9. Bandyk DF. vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg. 2008;21:119–123
  10. Fontaine R, Klm M, Kieny R. Die chirurgische Behandlungen der peripheren Durchblutungsstörungen. Helv Chir Acta. 1955;36:499–533
  11. Giske C, Monnet D, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52:813–820
  12. Ortega B, Groeneveld J, Schultsz C. Endemic multi-drug resistant Pseudomonas aeruginosa in critically ill patients. Infect Control Hosp Epidemiol. 2004;25:825–831
  13. Kang C, Kim S, Park W, Lee K, Kim H, Kim E, et al. Risk factors for antimikrobial resistance and influence of resistance on mortality in patients with bloodstream infections caused by Pseudomonas aeruginosa. Microb Drug Resist. 2005;11:68–74
  14. Sawyer R, Pruett T. Wound infections. Surg Clin North Am. 1994;74:519–536
  15. Kent K, Bartek S, Kuntz K, Anninos E, Skillman J. Prospective study of wound complications in continuous infrainguinal incisions after lower limb arterial reconstructions: Incidence, risk factors and cost. Surgery. 1996;119:378–383
  16. Richet H, Chidiac C, Prat A, Pol A, David M, Maccario M, et al. Analysis of risk factors for surgical wound infections following vascular surgery. Am J Med. 1991;91:170–172S
  17. Bandyk D, Back M. Infection in prosthetic vascular grafts. In: Rutherford  editors. Vascular surgery. Philadelphia: Elsevier Saunders; 2005;p. 875

 Competition of interest: none.

PII: S0741-5214(09)01228-2

doi: 10.1016/j.jvs.2009.05.063

Journal of Vascular Surgery
Volume 50, Issue 4 , Pages 806-812 , October 2009

Article Tools

* Image Usage & Resolution